TEAM (Thiotepa, Etoposide, Cytosar, Melphalan ) for AutoSCT in Lymphoma

Clinical trial NCT03346096 · COMPLETED

Trial details

NCT number: NCT03346096
Sponsor: Sheba Medical Center
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Malignant Lymphoma

Start date: 2018-10-09
Primary completion: 2024-06-30
Enrollment: 50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.